Companies · Healthtech

Health Essentials Holdings, Inc.

Irvine · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Health Essentials Holdings, Inc. — recommendation, valuation, rhythm, risks.
$61.9M
Total raised · real
4
Rounds
0.1×
Latest step-up
Top 8%
Sector rank · raised
Series C
Latest stage · inferred · Wed Mar 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Health Essentials Holdings, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.03× the median modeled value of Series C Healthtech companies in 2019–2021 (33 peers) — value vs value, same stage and era.
Dormant
  • Last raise 7.3 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Health Essentials Holdings, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
13.7 yr record
Peak capital year was 2012 with $51.2M across 1 filings.
Market position
ahead of 93% of Healthtech peers
Capital scale is ahead of 93% of Healthtech peers; modeled value is above 52% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2012: $51.2M across 1 filings.
  • Largest single filing was $51.2M on 2012-10-10.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Health Essentials Holdings, Inc. is one of 2138 Healthtech companies tracked from Irvine. By capital raised it ranks among the largest (ahead of 93% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2019-03-13
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeries C · 2012-10-10 Raised $51M (real) Modeled valuation $1.3B (est)$51M$1.3BSeries C2012Series C · 2013-07-31 Raised $1.0M (real) Modeled valuation $26M (est)$1.0M$26MSeries C2013Series C · 2017-06-19 Raised $8.5M (real) Modeled valuation $217M (est)$8.5M$217MSeries C2017Series C · 2019-03-13 Raised $1.2M (real) Modeled valuation $32M (est)$1.2M$32MSeries C2019+$1.0M+$8.5M+$1.2MCumulative $62M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series C$51.2M · 2012
Series C extension$1.0M · 2013
Series C extension$8.5M · 2017
Series C extension$1.2M · 2019

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 20%.

Modeled valuation trajectory
$31.5M
Base estimate est.
$4.5M
Conservative case
$83.1M
Upside case
$8.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series C · modeled $1.3B · 2012-10-102012Series C · modeled $25.7M · 2013-07-31Series C · modeled $217.4M · 2017-06-19Series C · modeled $31.5M · 2019-03-132019
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.32×/yr
Annual markup
1.51×/yr upside case
6.0 yr
Elapsed time used
7.3 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
26 mo
Avg between rounds
$9.6M/yr
Capital velocity
13.7 yr
On record since
2012
First round
4
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 14× above median
This company$61.9M
Sector median$4.5M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.0× of median
This company$1.2M
Sector median$46.5M
Modeled value — vs sector median (estimate, all stages) 0.9× of median
This company$31.5M
Sector median$33.8M

Raised more than 93% of sector peers (real $). Modeled value above 52% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #32 of 33.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Virta Health Corp. · Series C Raised $122.0M · modeled $2.4B (est)Fresenius Medical Care Voorhees, LLC · Series C Raised $71.1M · modeled $1.8B (est)Clear Health Pass Holdings LLC · Series C Raised $100.0M · modeled $1.8B (est)Zealth, Inc. · Series C Raised $95.0M · modeled $1.7B (est)Jawbone Health Hub, Inc. · Series C Raised $65.4M · modeled $1.7B (est)Boston Health Economic Holdings, LLC · Series C Raised $63.0M · modeled $1.6B (est)PWN Health Holdings, Inc. · Series C Raised $61.8M · modeled $1.5B (est)Quartet Health, Inc. · Series C Raised $127.0M · modeled $1.4B (est)Workit Health, Inc. · Series C Raised $87.9M · modeled $1.4B (est)Ajax Health II LLC · Series C Raised $51.0M · modeled $1.3B (est)Eden Health, Inc. · Series C Raised $73.4M · modeled $1.3B (est)NeuSpera Medical Inc. · Series C Raised $88.6M · modeled $1.3B (est)Health Essentials Holdings, Inc. (this company) Raised $61.9M · modeled $31.5M (est)Health Essentials Holdings, Inc.
CompanyStageRaised · realValue · estvs peer med.
Virta Health Corp.Series C$122.0M$2.4B2.19×
Fresenius Medical Care Voorhees, LLCSeries C$71.1M$1.8B1.67×
Clear Health Pass Holdings LLCSeries C$100.0M$1.8B1.67×
Zealth, Inc.Series C$95.0M$1.7B1.55×
Jawbone Health Hub, Inc.Series C$65.4M$1.7B1.54×
Boston Health Economic Holdings, LLCSeries C$63.0M$1.6B1.48×
PWN Health Holdings, Inc.Series C$61.8M$1.5B1.39×
Quartet Health, Inc.Series C$127.0M$1.4B1.29×
Workit Health, Inc.Series C$87.9M$1.4B1.27×
Ajax Health II LLCSeries C$51.0M$1.3B1.20×
Eden Health, Inc.Series C$73.4M$1.3B1.19×
NeuSpera Medical Inc.Series C$88.6M$1.3B1.19×
Health Essentials Holdings, Inc. this companySeries C$61.9M$31.5M0.03×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series C$51.2M2012-10-10$341.2M$1.3B85%
Series C$1.0M2013-07-31$6.7M$25.7M85%
Series C$8.5M2017-06-19$56.7M$217.4M90%
Series C$1.2M2019-03-13$8.2M$31.5M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series C$51.2M2012-10-10
    • First recorded raise — entered as Series C.
    • 11 investors on this round.
  2. Series C$1.0M2013-07-31
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 50.9× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  3. Series C$8.5M2017-06-19
    • Raised again after 47 mo — slower than the ~14 mo sector norm.
    • Round 8.4× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 7 investors on this round.
  4. Series C$1.2M2019-03-13
    • Raised again after 21 mo — slower than the ~14 mo sector norm.
    • Round 6.9× smaller than the prior — bridge or down round.
    • 3 investors on this round.
Intelligence
2021 ~Q2
Modeled next raise · ~26mo cadence
$1.2M
Modeled next size est.range $1.2M$2.0M
0.1×
Last step-up
$9.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Stephen Kraus6 other2012-10
Darren Black5 other2012-10
Thomas Flynn3 other2012-10
Kim Phan2 other2013-07
Thomas J. Flynn2 other2017-06
Alan Hoops1 other2013-07
Richard Slager1 other2017-06
Alan J. Hoops2017-06
Allen Bauzon2013-07
David J. Fitzgerald2017-06
Jerry J. Lyden2019-03
Kim J. Phan2017-06
Larry Nabb2019-03
Les Granow2013-07
Rick Slager2013-07
Ryan J. Jessop2019-03
Stephen J. Kraus2017-06
Registry & provenance

Health Essentials Holdings, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1560686
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Jet Health, Inc.HealthtechSeries B$38.9M$29.3Mnetwork2 shared operators · same sector
Artemis Health Inc.HealthtechSeries B$46.4M$566.7Mnetwork1 shared operator · same sector
Centaur Health Holdings, Inc.HealthtechSeries C$71.0M$38.7Msame sector · same stage
Upfront Healthcare Services, Inc.HealthtechSeries C$94.1M$34.5Msame sector · same stage
Alcresta Therapeutics, Inc.BiotechnologySeries C$75.9M$409.6Mnetwork1 shared operator · same stage
Mural Health Technologies, Inc.HealthtechSeries A$20.2M$69.6Mnetwork1 shared operator · same sector
Allena Pharmaceuticals, Inc.PharmaceuticalsSeries C$80.5M$75.1Mnetwork1 shared operator · same stage
Shape Memory Medical Inc.HealthtechSeries B$61.8M$22.9Msame sector
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Essential Medical, Inc.HealthtechSeries A$135.4M93%
Essential Health Solutions Inc.HealthtechSeries A$92.8M92%
AMM Health Holdings, LLCHealthtechSeries A$187.0M87%
Healthcare Solutions Holdings IncHealthtechSeries A$56.4M87%
Medical Innovation Holdings, Inc.HealthtechPre-Seed$10.1M87%
Standard Wellness Holdings, LLCHealthtechPre-Seed$3.3M87%
Como Health Holdings, LLCHealthtechSeed$10.2M87%
What About Health, Inc.HealthtechPre-Seed$7.6M86%
Frequently asked
How much funding has Health Essentials Holdings, Inc. raised?
Health Essentials Holdings, Inc. has raised approximately $61.9M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is Health Essentials Holdings, Inc.'s estimated valuation?
Provath's modeled valuation for Health Essentials Holdings, Inc. is approximately $31.5M (modeled range $4.5M–$83.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Health Essentials Holdings, Inc. at?
Health Essentials Holdings, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Wed Mar 13.
What does Health Essentials Holdings, Inc. do and where is it based?
Health Essentials Holdings, Inc. operates in the Healthtech sector, based in Irvine.
Explore related

See where Health Essentials Holdings, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Health Essentials Holdings, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.